These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 17465678)
1. Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection. Oswald-Richter K; Grill SM; Leelawong M; Tseng M; Kalams SA; Hulgan T; Haas DW; Unutmaz D PLoS Pathog; 2007 Apr; 3(4):e58. PubMed ID: 17465678 [TBL] [Abstract][Full Text] [Related]
2. Accelerated in vivo proliferation of memory phenotype CD4+ T-cells in human HIV-1 infection irrespective of viral chemokine co-receptor tropism. Zhang Y; de Lara C; Worth A; Hegedus A; Laamanen K; Beverley P; Macallan D PLoS Pathog; 2013; 9(4):e1003310. PubMed ID: 23637601 [TBL] [Abstract][Full Text] [Related]
3. Effects of human immunodeficiency virus type 1 infection on CCR5 and CXCR4 coreceptor expression on CD4 T lymphocyte subsets in infants and adolescents. Tuttle DL; Coberley CR; Xie X; Kou ZC; Sleasman JW; Goodenow MM AIDS Res Hum Retroviruses; 2004 Mar; 20(3):305-13. PubMed ID: 15117454 [TBL] [Abstract][Full Text] [Related]
4. Segregation of R5 and X4 HIV-1 variants to memory T cell subsets differentially expressing CD62L in ex vivo infected human lymphoid tissue. Gondois-Rey F; Grivel JC; Biancotto A; Pion M; Vigne R; Margolis LB; Hirsch I AIDS; 2002 Jun; 16(9):1245-9. PubMed ID: 12045489 [TBL] [Abstract][Full Text] [Related]
5. R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1. Schweighardt B; Roy AM; Meiklejohn DA; Grace EJ; Moretto WJ; Heymann JJ; Nixon DF J Virol; 2004 Sep; 78(17):9164-73. PubMed ID: 15308712 [TBL] [Abstract][Full Text] [Related]
6. Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy. Ribeiro RM; Hazenberg MD; Perelson AS; Davenport MP J Virol; 2006 Jan; 80(2):802-9. PubMed ID: 16378982 [TBL] [Abstract][Full Text] [Related]
7. A CCR5 Terahara K; Iwabuchi R; Hosokawa M; Nishikawa Y; Takeyama H; Takahashi Y; Tsunetsugu-Yokota Y BMC Res Notes; 2019 Apr; 12(1):242. PubMed ID: 31036079 [TBL] [Abstract][Full Text] [Related]
8. Selective infection of CD4+ effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD/SCID/IL-2Rgammanull mice. Nie C; Sato K; Misawa N; Kitayama H; Fujino H; Hiramatsu H; Heike T; Nakahata T; Tanaka Y; Ito M; Koyanagi Y Virology; 2009 Nov; 394(1):64-72. PubMed ID: 19744686 [TBL] [Abstract][Full Text] [Related]
9. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers. Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989 [TBL] [Abstract][Full Text] [Related]
10. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques. Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156 [TBL] [Abstract][Full Text] [Related]
11. Differential susceptibility of naïve, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission. Groot F; van Capel TM; Schuitemaker J; Berkhout B; de Jong EC Retrovirology; 2006 Aug; 3():52. PubMed ID: 16916447 [TBL] [Abstract][Full Text] [Related]
12. Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells. Vyakarnam A; Eyeson J; Teo I; Zuckerman M; Babaahmady K; Schuitemaker H; Shaunak S; Rostron T; Rowland-Jones S; Simmons G; Clapham P AIDS; 2001 Sep; 15(13):1613-26. PubMed ID: 11546935 [TBL] [Abstract][Full Text] [Related]
13. Naïve and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implicatip6s for transmission and pathogenesis. Riley JL; Levine BL; Craighead N; Francomano T; Kim D; Carroll RG; June CH J Virol; 1998 Oct; 72(10):8273-80. PubMed ID: 9733871 [TBL] [Abstract][Full Text] [Related]
14. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection. de Roda Husman AM; Blaak H; Brouwer M; Schuitemaker H J Immunol; 1999 Oct; 163(8):4597-603. PubMed ID: 10510404 [TBL] [Abstract][Full Text] [Related]
15. Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection. Zaunders JJ; Ip S; Munier ML; Kaufmann DE; Suzuki K; Brereton C; Sasson SC; Seddiki N; Koelsch K; Landay A; Grey P; Finlayson R; Kaldor J; Rosenberg ES; Walker BD; Fazekas de St Groth B; Cooper DA; Kelleher AD J Virol; 2006 Oct; 80(20):10162-72. PubMed ID: 17005693 [TBL] [Abstract][Full Text] [Related]
16. Specific patterns of CD4-associated immunosenescence in vertically HIV-infected subjects. Méndez-Lagares G; Díaz L; Correa-Rocha R; León Leal JA; Ferrando-Martínez S; Ruiz-Mateos E; Pozo-Balado MM; Gurbindo MD; de José MI; Muñoz-Fernández MA; Leal M; Pacheco YM Clin Microbiol Infect; 2013 Jun; 19(6):558-65. PubMed ID: 22735071 [TBL] [Abstract][Full Text] [Related]
17. HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo. Meditz AL; Haas MK; Folkvord JM; Melander K; Young R; McCarter M; Mawhinney S; Campbell TB; Lie Y; Coakley E; Levy DN; Connick E J Virol; 2011 Oct; 85(19):10189-200. PubMed ID: 21813616 [TBL] [Abstract][Full Text] [Related]
18. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection. Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658 [TBL] [Abstract][Full Text] [Related]
20. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice. Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]